Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
Background: Ceftaroline represents a novel fifth-generation cephalosporin to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Methods: Ceftaroline susceptibility of 239 MRSA isolates was assessed by disk diffusion and a MIC test strip following both EUCAST and CLSI guid...
Main Authors: | Gianluca Morroni, Simona Fioriti, Federica Salari, Andrea Brenciani, Lucia Brescini, Marina Mingoia, Eleonora Giovanetti, Antonella Pocognoli, Andrea Giacometti, Elisa Molinelli, Annamaria Offidani, Oriana Simonetti, Oscar Cirioni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/8/1026 |
Similar Items
-
IN VITRO SUSCEPTIBILITY OF MRSA CLINICAL ISOLATES TO CEFTAROLINE
by: Muhammad Aurangzeb, et al.
Published: (2018-04-01) -
Evaluation of in vitro activity of ceftaroline on methicillin resistant Staphylococcus aureus blood isolates from Iran
by: Negin Abdizadeh, et al.
Published: (2021-08-01) -
Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study
by: Daniele Roberto Giacobbe, et al.
Published: (2021-06-01) -
Increased Antimicrobial Resistance of MRSA Strains Isolated from Pigs in Spain between 2009 and 2018
by: Rossana Abreu, et al.
Published: (2019-04-01) -
Antimicrobial Resistance, SCC<i>mec</i>, Virulence and Genotypes of MRSA in Southern China for 7 Years: Filling the Gap of Molecular Epidemiology
by: Junyan Liu, et al.
Published: (2023-02-01)